W. H. L. Hackeng

2.6k citations

73 papers · 2.0k indexed · 1 hit paper · h-index 22

Impact in

Nephrology top 1%
- Parathyroid Disorders and Treatments
- Chronic Kidney Disease and Diabetes
Orthopedics and Sports Medicine top 2%
- Bone health and osteoporosis research

Papers in

Nephrology 19
- Parathyroid Disorders and Treatments 17
Endocrinology, Diabetes and Metabolism 30
- Thyroid Disorders and Treatments 9
- Growth Hormone and Insulin-like Growth Factors 6
- Pituitary Gland Disorders and Treatments 5

Co-authors: J. J. P. Nauta A. J. M. Donker J. C. Netelenbos Paul Lips M. Jongen F C van Ginkel W. Schopman W. J. F. van der Vijgh
Journals: European Journal of Endocrinology (11 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)Journal of Endocrinology (5 papers)Clinical Endocrinology (3 papers)Journal of Molecular Medicine (3 papers)
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

W. H. L. Hackeng

67 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus 1992 · 442 citations

Peers

Countries citing papers authored by W. H. L. Hackeng

Since Specialization

Citations

This map shows the geographic impact of W. H. L. Hackeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. H. L. Hackeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. H. L. Hackeng more than expected).

Fields of papers citing papers by W. H. L. Hackeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. H. L. Hackeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. H. L. Hackeng. The network helps show where W. H. L. Hackeng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W. H. L. Hackeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. H. L. Hackeng Line = papers co-authored together W. H. L. Hackeng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF‐I generation after high‐dose GH treatment determines the growth response to GH Clinical Endocrinology ·Gerdine A. Kamp, A. H. Zwinderman, J. van Doorn, W. H. L. Hackeng, Michael A. Frölich, Eckhard Schönaü, Jan M. Wit	2002	27
2	Acute effects of etidronate on glucocorticoid‐induced bone degradation Lara D. Veeken ·Ard Struijs, A. G. H. Smals, 新治小金沢, W. H. L. Hackeng, Hindrik Mulder	2000	11
3	Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women European Journal of Clinical Pharmacology ·Joseph C. Koster, W. H. L. Hackeng, Hindrik Mulder	1996	38
4	Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia Diabetologia ·Jo W.M. Höppener, J. Sjef Verbeek, Eelco J.P. de Koning, Cor Oosterwijk, Srimuliati, Bernard Schweizer, Frans M.A. Hofhuis, D Sri Luwihana, M. Verté, W. H. L. Hackeng, H.S. Jansz, John F. Morris, Anne Clark, P J Capel, Cornelis J.M. Lips	1993	68
5	Plasma Concentrations of Islet Amyloid Polypeptide After Glucagon Administration in Type 2 Diabetic Patients and Non‐diabetic Subjects Diabetic Medicine ·Brigit C. van Jaarsveld, W. H. L. Hackeng, C.J.M. Lips, D.W. Erkelens	1993	10
6	Calcitonin gene-related peptide, the menstrual cycle and premenstrual syndrome Gynecological Endocrinology ·GAIL BURRELL GERRY, H. P. F. Koppeschaar, Willem J. Kop, Egbert R. te Velde, W. H. L. Hackeng, A.A. Haspels	1992	1
7	Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus The Lancet ·MYRA UNDERWOOD KEEYS, Eddy Robert Mamani Sanga, ROBIN SCROGGS, W. H. L. Hackeng, A. J. M. Donker, J. J. P. Nauta Hit paper breakdown →	1992	442
8	Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis Journal of Hepatology ·A.A. van Vliet, W. H. L. Hackeng, A. J. M. Donker, S.G.M. Meuwissen	1992	8
9	Diurnal Variation in Urinary Protein Excretion in Diabetic Nephropathy Nephrology Dialysis Transplantation ·Coen D.A. Stehouwer, Q. P. Hu, W. H. L. Hackeng, G.J.H. den Ottolander, A. J. M. Donker	1991	7
10	Effect of a Single Infusion of Aminohydroxypropylidene on Calcium and Bone Metabolism in Healthy Volunteers Monitored during 2 Months The Journal of Clinical Endocrinology & Metabolism ·J. C. Netelenbos, F C van Ginkel, P. Lips, Oscar Leeuwenkamp, Rob Barto, W. J. F. van der Vijgh, Patakas Bm, W. H. L. Hackeng	1991	19
11	Twenty-Four-Hour Plasma Growth Hormone (GH) Profiles, Urinary GH Excretion, and Plasma Insulin-Like Growth Factor-I and -II Levels in Prepubertal Children with Chronic Renal Insufficiency and Severe Growth Retardation* The Journal of Clinical Endocrinology & Metabolism ·Anita C. S. Hokken‐Koelega, W. H. L. Hackeng, Theo Stijnen, Jan M. Wit, Sabine M.P.F. de Muinck Keizer‐Schrama, S. L. S. Drop	1990	95
12	139 CALCIUM(Ca) AND PHOSPHATE(P) METABOLISM IN PRETERM INFANTS ON A FORMULA WITH 5 OR 40% MEDIUM-CHAIN TRIGLYCERIDES(MCT) Pediatric Research ·Esther Sulkers, Harry N. Lafeber, Choon Ho Son, Jan Lindemans, W. H. L. Hackeng, H.J. Degenhart, P J J Sauer	1990	1
13	Vitamin D Metabolism in Breast-Fed Infants and their Mothers Pediatric Research ·Theo Hoogenboezem, H.J. Degenhart, Sabine M.P.F. de Muinck Keizer‐Schrama, Roger Bouillon, W. F. A. Grose, W. H. L. Hackeng, H. K. A. Visser	1989	54
14	The Effect of Vitamin D Supplementation on Vitamin D Status and Parathyroid Function in Elderly Subjects* The Journal of Clinical Endocrinology & Metabolism ·Paul Lips, A Wiersinga, F C van Ginkel, M. Jongen, J. C. Netelenbos, W. H. L. Hackeng, P. D. Delmas, W. J. F. van der Vijgh	1988	309
15	Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure BMJ ·D. E. Grobbee, W. H. L. Hackeng, J.C. Birkenhäger, Albert Hofman	1988	48
16	Stimulation of calcitonin secretory capacity by increased serum levels of testosterone in men treated with tamoxifen International Journal of Andrology ·W. Schopman, Nurul Fitrawati, W. H. L. Hackeng, Hindrik Mulder	1987	1
17	End-organ resistance to PTH infusion in hypercalcaemic and normocalcaemic patients with solid tumours European Journal of Endocrinology ·Yoshihiko Kageyama, Q. P. Hu, Hanni Audi Chesyta Zihni, Hindrik Mulder, W. H. L. Hackeng, W. Schopman, Jon Livingston, J. Silberbusch	1986	4
18	Secretion of adrenocorticotropin, β -endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressin European Journal of Endocrinology ·R. Oosterom, T. Verleun, Hajo A. Bruining, W. H. L. Hackeng, Steven W. J. Lamberts	1986	7
19	Enhanced Calcitonin Release in Chronic Renal Failure Depending on the Absence of Severe Secondary Hyperparathyroidism The Nephron journals/Nephron journals ·Hindrik Mulder, J. Silberbusch, W. H. L. Hackeng, Jon Livingston, G.J.H. den Ottolander	1982	10
20	Untersuchungen zur Parathyreoidea-Funktion bei chronisch hämodialysierten Patienten Journal of Molecular Medicine ·R. Augustin, W. H. L. Hackeng	1977	1

About W. H. L. Hackeng

W. H. L. Hackeng is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Behavioral Neuroscience, Orthopedics and Sports Medicine and Oncology, having authored 73 papers that have together received 2.0k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (17 papers), Bone health and treatments (13 papers), Thyroid Disorders and Treatments (9 papers), Vitamin D Research Studies (7 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Bone health and osteoporosis research (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Nephrology (392 citations), Orthopedics and Sports Medicine (358 citations), Endocrinology, Diabetes and Metabolism (526 citations), Pathology and Forensic Medicine (528 citations) and Nutrition and Dietetics (227 citations). W. H. L. Hackeng has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include J. J. P. Nauta, A. J. M. Donker, J. C. Netelenbos, Paul Lips, M. Jongen, F C van Ginkel, W. Schopman, W. J. F. van der Vijgh, P. D. Delmas and A Wiersinga. Their work appears in journals such as European Journal of Endocrinology, The Journal of Clinical Endocrinology & Metabolism, Journal of Endocrinology, Clinical Endocrinology and Journal of Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact